GlassScriptPhysician profile
Anna Marie Robinson
NPI 1205307519
$2,216.41
in general payments reported to CMS, 2019-2025
12 companies · $52.42 in 2025
The $52.42 reported for 2025 was less than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $636 · 2022: $824 · 2023: $569 · 2024: $135 · 2025: $52.42.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $756.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $756.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $1,456.00 | 2021-2024 | Edwards Sapien 3 Ultra Transcatheter Heart Valve, Sapien 3 Ultra Resilia |
| Boston Scientific Corporation | $171.78 | 2022-2024 | |
| Amgen INC. | $118.19 | 2021-2023 | Repatha |
| Heartflow, INC. | $89.60 | 2022-2023 | Ffrct |
| Seagen INC. | $81.80 | 2021-2022 | |
| Pfizer INC. | $64.36 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $49.00 | 2024-2025 | Tagrisso |
| Abbott Laboratories | $48.67 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $47.90 | 2021-2022 | |
| Corcept Therapeutics | $43.77 | 2023 | Korlym |
| Janssen Biotech, INC. | $24.66 | 2025 | Rybrevant |
| Takeda Pharmaceuticals U.S.A., INC. | $20.68 | 2024 | Fruzaqla |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anna Robinson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.